![Marino Garcia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marino Garcia
Amministratore Delegato presso
DIANTHUS THERAPEUTICS, INC.
Patrimonio netto: 7 M $ in data 31/07/2026
Profilo
Marino Garcia is currently President, Chief Executive Officer & Director at Dianthus Therapeutics OpCo, Inc. since 2021 and holds the same titles at Dianthus Therapeutics, Inc. since 2023.
Former positions include Vice President-Business Development at Aptalis Pharma Canada ULC from 2010 to 2014, Vice President-US Commercial Operations at Aspreva Pharmaceuticals Corp.
from 2006 to 2010, Senior VP-Corporate & Business Development at Zealand Pharma A from 2018 to 2021, and Chief Strategy Officer & Executive Vice President at Synergy Pharmaceuticals LLC from 2016 to 2018.
Education includes an undergraduate degree from Concordia University and an MBA from Richard Ivey School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 07/08/2026 | 65.292 ( 0,2% ) | 7 M $ | 31/07/2026 |
Posizioni attive di Marino Garcia
| Società | Posizione | Inizio |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Amministratore Delegato | 11/09/2023 |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Amministratore Delegato | 01/11/2021 |
Precedenti posizioni note di Marino Garcia
| Società | Posizione | Fine |
|---|---|---|
| ZEALAND PHARMA A/S | Corporate Officer/Principal | 01/10/2021 |
| SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 30/09/2018 |
Aptalis Pharma Canada ULC
 Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Corporate Officer/Principal | 13/03/2014 |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2010 |
Formazione di Marino Garcia
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
61
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Aptalis Pharma Canada ULC
Aptalis Pharma Canada ULC Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Concordia University
 Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dianthus Therapeutics, Inc. (Massachusetts)
Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Develops therapies for severe autoimmune diseases | Health Technology |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
